Clinical Trial Site

Geneva 1205

2 studies enrolling now · 3 studies all time

What they study most

Cerebral Amyloid Angiopathy, High Cardiovascular Risk, Hypertension, Transthyretin Amyloidosis With Cardiomyopathy

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy — Recruiting now
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed